[Pharmacokinetic studies on H3-digoxin and H3-lanatosid in man]. 1973

H J Dengler, and G Bodem, and K Wirth

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007799 Lanatosides Glycosides from DIGITALIS lanata leaf. Lanatoside C has actions similar to DIGOXIN. Mixtures of lanatosides A, B, and C have also been used. (From Martindale, The Extra Pharmacopoeia, 30th ed, p670) Digilanides
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004074 Digitoxin A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665) Coramedan,Digimed,Digimerck,Digitaline Nativelle,Digitoxin AWD,Digitoxin Bürger,Digitoxin Didier,Digitoxin-Philo,Digophton,AWD, Digitoxin,Bürger, Digitoxin,Didier, Digitoxin,Digitoxin Philo,Nativelle, Digitaline
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005260 Female Females

Related Publications

H J Dengler, and G Bodem, and K Wirth
January 1973, Clinical pharmacology and therapeutics,
H J Dengler, and G Bodem, and K Wirth
September 1976, Current therapeutic research, clinical and experimental,
H J Dengler, and G Bodem, and K Wirth
January 1978, Arzneimittel-Forschung,
H J Dengler, and G Bodem, and K Wirth
November 1986, British journal of clinical pharmacology,
H J Dengler, and G Bodem, and K Wirth
April 1971, Arzneimittel-Forschung,
H J Dengler, and G Bodem, and K Wirth
January 1986, International journal of clinical pharmacology, therapy, and toxicology,
H J Dengler, and G Bodem, and K Wirth
July 1977, International journal of clinical pharmacology and biopharmacy,
H J Dengler, and G Bodem, and K Wirth
November 1972, The Annals of occupational hygiene,
H J Dengler, and G Bodem, and K Wirth
July 1973, Arzneimittel-Forschung,
H J Dengler, and G Bodem, and K Wirth
June 1976, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!